Search the Newsreel

DHI Group, Inc. 2Q 2026: Revenue $31.34M, EPS $0.06— 10-Q Summary

DHI Group, Inc. (DHX) reported its second-quarter 2026 results, showing a slight year-over-year revenue decrease to $31.34 million but an improvement in net income to $2.6 million, resulting in diluted EPS of $0.06. The company experienced mixed performance across its segments, with ClearanceJobs growing …

DHI Group Inc reports results for the quarter ended June 30 - Earnings Summary

DHI Group Inc has released its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters, provides a brief overview of these results. Users can access the full report and further analysis on TradingView.

DHI Group, Inc. (NYSE: DHX) posts Q2 profit as ClearanceJobs grows

DHI Group, Inc. (NYSE: DHX) reported a return to profitability in Q2 2026, with net income of $2.597 million and diluted EPS of $0.06, compared to a net loss in the prior year. This positive performance was primarily driven by the strong growth of …

DHI Group (DHX) Q2 Earnings and Revenues Beat Estimates

DHI Group (DHX) reported Q2 earnings of $0.09 per share, exceeding the Zacks Consensus Estimate of $0.07, and revenues of $31.34 million, also surpassing estimates. This marks the fourth consecutive quarter the company has beaten both EPS and revenue expectations. Despite the strong performance …

Sei Investments Co. Has $5.07 Million Stock Holdings in DHI Group, Inc. $DHX

Sei Investments Co. significantly increased its stake in DHI Group, Inc. (DHX) by 108.9% in the first quarter, now holding 1,804,281 shares valued at $5.07 million. DHI Group reported strong quarterly earnings and revenue, beating analyst estimates, with projections for continued profitability. While some …

Butterfly Gandhimathi net profit rises 38% in Q1FY27 on revenue growth

D.R. Horton, Inc. $DHI Shares Bought by CX Institutional

CX Institutional increased its stake in D.R. Horton (DHI) by 20.7% in the second quarter, bringing its holdings to 51,677 shares valued at $8.4 million. Other institutional investors also adjusted their positions, with institutional ownership of DHI now standing at 90.63%. The company reported …

D.R. HORTON, INC. : WELLS FARGO CUTS TARGET PRICE TO $155 FROM $170

Wells Fargo has reduced its target price for D.R. Horton, Inc. (DHI.N) from $170 to $155. This announcement was made by Reuters, indicating a change in the financial institution's outlook on the homebuilder's stock. The article states that its content reflects solely the author's …

Price to earnings forward of Radhika Jeweltech Ltd – NSE:RADHIKAJWE

D.R. Horton, Inc. Revenue Breakdown – LSX:884312

D.R. Horton, Inc. generated €29.19 billion in revenue last year, with its Homebuilding segment contributing €26.86 billion, down from €30.50 billion the previous year. The United States was the primary geographic contributor, accounting for the entire €29.19 billion, a decrease from €33.05 billion in …

D.R. Horton Inc. stock underperforms Monday when compared to competitors despite daily gains

D.R. Horton Inc. stock advanced 2.52% to $146.66 on Monday, breaking a three-day losing streak, despite the broader market's strong performance. The S&P 500 Index rose 1.48% and the Dow Jones Industrial Average increased by 1.32%. Despite its daily gains, D.R. Horton Inc. underperformed …

D.R. Horton, Inc. (NYSE:DHI) Receives Average Recommendation of "Hold" from Analysts

D.R. Horton, Inc. (NYSE:DHI) has received an average "Hold" rating from analysts, with a consensus 12-month price target of $168.17, which is above its recent opening price. The homebuilder recently surpassed earnings and revenue expectations, reporting $3.20 EPS and $9.23 billion in revenue. Institutional …

Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development

RedHill Biopharma Ltd. provided an update on the development of opaganib for Ebola virus disease (EVD) as confirmed Bundibugyo ebolavirus cases and deaths have substantially increased. The company is in discussions with African health authorities and research institutions regarding the potential use of opaganib, …

Quantinno Capital Management LP Acquires 17,354 Shares of D.R. Horton, Inc. $DHI

Quantinno Capital Management LP increased its stake in D.R. Horton, Inc. by 10.8% in the first quarter, now owning 177,412 shares valued at approximately $24.3 million. Other institutional investors also adjusted their positions, with overall institutional ownership remaining high at 90.63%. D.R. Horton exceeded …

D.R. Horton, Inc. Revenue Breakdown – TRADEGATE:HO2

D.R. Horton, Inc. generated €29.19 billion in revenue last year, with the Homebuilding segment contributing the most at €26.86 billion. All of the company's revenue came from the United States, which accounted for €29.19 billion. This marks a decrease from the previous year's revenue …

D.R. Horton, Inc. $DHI Shares Sold by Argent Capital Management LLC

Argent Capital Management LLC reduced its stake in D.R. Horton (NYSE:DHI) by 3.6% in the first quarter, selling 18,809 shares but still holding over 507,000 shares valued at $69.6 million. Despite some institutional selling, others increased their holdings, and institutional investors collectively own 90.63% …

DHI6065348 Bond Profile — Key Metrics

This article provides key metrics for the DHI6065348 bond issued by D.R. Horton, Inc. The bond has a coupon rate of 4.85%, an issue date of May 5, 2025, and matures on October 15, 2030, with an outstanding amount of $500 million. D.R. Horton, …

Redhill Biopharma Ltd (RDHL) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Redhill Biopharma Ltd (RDHL), focusing on its stock price momentum, support and resistance levels, and various technical indicators. The current price momentum score is 4.70, ranking 44th in the Pharmaceuticals industry, with the stock trading between a …

D.R. Horton Inc. stock underperforms Thursday when compared to competitors

D.R. Horton Inc. (DHI) shares dropped 1.11% on Thursday, despite a strong trading session for the broader market with the S&P 500 and Dow Jones Industrial Average both rising. This marks the second consecutive day of losses for the stock.

Vidhi Specialty Food Ingredients profit rises 35% in Q1FY27 on revenue surge

Vidhi Specialty Food Ingredients Q1 Results: Net profit jumps 34% YoY to ₹171.3 crore

DHI Group (DHX) to Release Quarterly Earnings on Wednesday

DHI Group (DHX) is scheduled to release its Q2 2026 earnings after market close on Wednesday, August 5th, with analysts forecasting $0.07 earnings per share and $30.8950 million in revenue. The company previously surpassed expectations in Q1 2026. DHX shares have recently increased by …

D.R. Horton (DHI) Is Up 5.3% After Big Buyback And Flat Q3 Sales - Has The Bull Case Changed?

Vidhi Specialty Food Ingredients Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

DHI Group Inc (DHX) Financial Health: Profitability & Balance Sheet Analysis

DHI Group Inc (DHX) currently holds a financial score of 8.02, ranking 43rd out of 160 in the Professional & Commercial Services industry, indicating stable financial health and high operating efficiency. Despite this, its latest quarterly revenue decreased by 8.07% year-over-year, and its net …

DHX|DHI Group Inc|Price:4.130|Chg%:+0.020

DHI Group Inc (DHX) has a TradingKey Stock Score indicating relatively healthy fundamentals and significant growth potential, although its valuation is considered fairly valued within its industry. The company recently reported a turnaround to a loss, with institutional selling observed. Analysts, however, rate it …

DHI Group (NYSE: DHX) exec uses 1,459 shares to cover taxes

Alexander Schildt, President of ClearanceJobs at DHI Group, had 1,459 shares of common stock withheld at $3.85 per share to cover tax obligations from a restricted stock award's vesting. After this transaction, he directly holds 133,313 shares. This amount includes shares purchased through an …

DHI Group (NYSE: DHX) CLO has shares withheld to cover tax obligations

Edward Jack Connolly, Chief Legal Officer of DHI Group, had 1,372 shares of common stock withheld by the issuer to cover tax obligations upon the vesting of a restricted stock award. This transaction, valued at $3.85 per share, occurred on July 25, 2026. Following …

Bodhi Tree Multimedia Ltd. Revenue Breakdown – NSE:BTML

RedHill Biopharma (Nasdaq: RDHL) details opaganib plans amid Ebola surge

RedHill Biopharma has provided an update on its investigational antiviral opaganib for Ebola virus disease, amidst a growing outbreak of Bundibugyo ebolavirus with over 3,200 cases and 1,400 deaths by July 28, 2026. The company is actively discussing next-step planning and potential partnerships with …

DHI Group, Inc. (NYSE:DHX) Given Average Rating of "Moderate Buy" by Analysts

DHI Group, Inc. (NYSE:DHX) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $5.83. The company recently surpassed quarterly earnings expectations, reporting $0.08 per share on revenues of $29.69 million. While institutional investors own a significant portion …

Redhill Biopharma Ltd (RDHL) Institutional Confidence

This article from TradingKey provides an overview of Redhill Biopharma Ltd's (RDHL) institutional confidence, a component of its overall stock score. It lists institutional holdings and changes, showing that while some firms like Yorkville Advisors Global hold significant shares without recent changes, others like …

DHI Group Inc (DHX) Institutional Confidence

DHI Group Inc (DHX) currently has an institutional shareholding score of 7.00, placing it 74th within its industry. The institutional shareholding proportion is 74.92%, showing a slight decrease of 1.99% quarter-over-quarter. James Simons is the largest institutional shareholder, holding 4.38% of the shares outstanding.

DHI Group Inc (DHX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for DHI Group Inc (DHX), detailing its current earnings forecast score, analyst ratings, and price targets. It highlights that the company's earnings forecast score is 8.00, ranking 33rd in its industry, and analysts project an average price target …

Redhill Biopharma Ltd (RDHL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses Redhill Biopharma Ltd (RDHL) revenue breakdown but states that relevant data regarding business segments, regional revenue, and profit contribution have not been disclosed by the company yet. It provides current stock information, including the price, market cap, and P/E TTM. The …

Redhill Biopharma Ltd (RDHL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Redhill Biopharma Ltd (RDHL), stating that its current valuation score is 9.96, ranking 1st in the Pharmaceuticals industry. It highlights the company's P/E ratio of -7.00, which is significantly below its recent high. However, other key financial …